Global Orthobiologics Market 2024-2028

Global Orthobiologics Market 2024-2028

Global Orthobiologics Market 2024-2028

The orthobiologics market is forecasted to grow by USD 2768 mn during 2023-2028, accelerating at a CAGR of 7.75% during the forecast period. The report on the orthobiologics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of orthopedic disorders coupled with an aging population, increase in focus to reduce orthopedic surgeries, and rise in approvals and clearances for orthobiologics products.

Technavio's orthobiologics market is segmented as below:

• By Application
• Spinal fusion
• Reconstructive surgery
• Trauma repair
• Others
• By Product
• Bone graft substitutes
• Viscosupplementation
• Stem cells
• By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increase in development of new products as one of the prime reasons driving the orthobiologics market growth during the next few years. Also, emerging technological innovations and rise in popularity of orthobiologics will lead to sizable demand in the market.

The report on the orthobiologics market covers the following areas:

• Orthobiologics market sizing
• Orthobiologics market forecast
• Orthobiologics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading orthobiologics market vendors that include Advanced Medical Solutions Group Plc, Anika Therapeutics Inc., Arthrex Inc., Bioventus LLC, Globus Medical Inc., Institut Straumann AG, Integra Lifesciences Corp., Johnson and Johnson Services Inc., Kuros Biosciences AG, Medtronic Plc, MTF Biologics, Nuvasive Inc., Orthofix Medical Inc., OrthoPediatrics Corp., ROYAL BIOLOGICS, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Xtant Medical Holdings Inc., and Zimmer Biomet Holdings Inc.. Also, the orthobiologics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.